other material
confidence high
sentiment negative
materiality 0.70
MIRA PHARMACEUTICALS, INC. (MIRA): auditor change — MIRA Pharmaceuticals replaces auditor Cherry Bekaert with Salberg; material weaknesses cited
MIRA PHARMACEUTICALS, INC.
- Cherry Bekaert resigned as auditor effective Dec 16, 2024; no disagreements but noted material weaknesses in internal controls for 2022 and 2023.
- Salberg & Company P.A. engaged as new independent auditor for fiscal year ending Dec 31, 2024, effective Dec 18.
- Cherry Bekaert's prior reports included a going concern explanatory paragraph.
- No disagreements or reportable events other than the material weaknesses.